BRD2 and chromophobe renal cell carcinoma: The downregulation of argininosuccinate synthetase (ASS1), phosphoglycerate dehydrogenase (PHGDH), and glutamic-oxaloacetic transaminase 1 and 2 (GOT1 and GOT2) in both chRCC and RO tumors compared with NAT confirms this result [24].